NCT04468633View on ClinicalTrials.gov

The Baerveldt Versus ClearPath Comparison Study

NACompletedINTERVENTIONAL

Enrollment

76

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

June 29, 2023

Study Completion Date

June 29, 2023

Conditions

Glaucoma

Interventions

DEVICE

Baerveldt 350 implant

The Baerveldt implant is an FDA-approved silicone, non-valved implant.

DEVICE

Ahmed ClearPath 350 implant

The Ahmed ClearPath is a non-valved glaucoma drainage device.

Trial Locations (1)

27705

Duke Eye Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER